Citations

Mayo Clinic

Showing 10 of 108572 citations.

SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice
Percopo, Caroline M. , Brenner, Todd A. , Kraemer, Laura S , Hakeem, Reem M A, Lee, James J. , Rosenberg, Helene F. , Ma, Michelle

Journal of Leukocyte Biology | August 17, 2016 | Volume: 101 | Issue: 1 | Pages: 321-328

10.1189/jlb.3a0416-166r | PMID 27531929 Get It

Abstract Although eosinophils as a group are readily identified by their unique morphology and staining properties, flow cytometry provides an important means for identification of subgroups based on differential expression of distinct surface Ags. Here, we characterize an eosinophil subpopulation defined by high levels of expression of the neutrophil Ag Gr1 (CD45+CD11c−SiglecF+Gr1hi). SiglecF+Gr1hi eosinophils, distinct from the canonical SiglecF+Gr1− eosinophil population, were detected in allergen-challenged wild-type and granule protein-deficient (EPX−/− and MBP-1−/−) mice, but not in the eosinophil-deficient ΔdblGATA strain. In contrast to Gr1+ neutrophils, which express both cross-reacting Ags Ly6C and Ly6G, SiglecF+Gr1hi eosinophils from allergen-challenged lung tissue are uniquely Ly6G+. Although indistinguishable from the more-numerous SiglecF+Gr1− eosinophils under light microscopy, FACS-isolated populations revealed prominent differences in cytokine contents. The lymphocyte-targeting cytokines CXCL13 and IL-27 were identified only in the SiglecF+Gr1hi eosinophil population (at 3.9 and 4.8 pg/106 cells, respectively), as was the prominent proinflammatory mediator IL-13 (72 pg/106 cells). Interestingly, bone marrow-derived (SiglecF+), cultured eosinophils include a more substantial Gr1+ subpopulation (∼50%); Gr1+ bmEos includes primarily a single Ly6C+ and a smaller, double-positive (Ly6C+Ly6G+) population. Taken together, our findings characterize a distinct SiglecF+Gr1hi eosinophil subset in lungs of allergen-challenged, wild-type and granule protein-deficient mice. SiglecF+Gr1hi eosinophils from wild-type mice maintain a distinct subset of cytokines, including those active on B and T lymphocytes. These cytokines may facilitate eosinophil-mediated immunomodulatory responses in the allergen-challenged lung as well as in other distinct microenvironments.
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes
Thompson, Patricia A. , Ashbeck, Erin L., Roe, Denise J. , Fales, Liane, Buckmeier, Julie A., Wang, Fang , Bhattacharyya, A. K. , Hsu, Chiu‐Hsieh , Chow, H.‐H. Sherry , Ahnen, Dennis J. , Heigh, Russell I., Fay, David E., Jacobs, Elizabeth T. , Alberts, David S., Lance, Peter , Buckmeier, Julie, Bhattacharyya, Achyut, Boland, C. Richard , Hamilton, Stanley R. , Martı́nez, Marı́a Elena

JNCI: Journal of the National Cancer Institute | August 17, 2016 | Volume: 108 | Issue: 12 | Pages: No page available

10.1093/jnci/djw152 | PMID 27530657 Get It

Insulin does not stimulate muscle protein synthesis during increased plasma branched-chain amino acids alone but still decreases whole body proteolysis in humans
Everman, Sarah , Tran, Lee , Hoffman, Nyssa, Carroll, Chad C. , Dedmon, William L., Katsanos, Christos S. , Meyer, Christian , Katsanos, Christos S

American Journal of Physiology-Endocrinology and Metabolism | August 16, 2016 | Volume: 311 | Issue: 4 | Pages: E671-E677

10.1152/ajpendo.00120.2016 | PMID 27530230 Get It

Insulin stimulates muscle protein synthesis when the levels of total amino acids, or at least the essential amino acids, are at or above their postabsorptive concentrations. Among the essential amino acids, branched-chain amino acids (BCAA) have the primary role in stimulating muscle protein synthesis and are commonly sought alone to stimulate muscle protein synthesis in humans. Fourteen healthy young subjects were studied before and after insulin infusion to examine whether insulin stimulates muscle protein synthesis in relation to the availability of BCAA alone. One half of the subjects were studied in the presence of postabsorptive BCAA concentrations (control) and the other half in the presence of increased plasma BCAA (BCAA). Compared with that prior to the initiation of the insulin infusion, fractional synthesis rate of muscle protein (%/h) did not change ( P > 0.05) during insulin in either the control (0.04 ± 0.01 vs 0.05 ± 0.01) or the BCAA (0.05 ± 0.02 vs. 0.05 ± 0.01) experiments. Insulin decreased ( P < 0.01) whole body phenylalanine rate of appearance (μmol·kg−1·min−1), indicating suppression of muscle proteolysis, in both the control (1.02 ± 0.04 vs 0.76 ± 0.04) and the BCAA (0.89 ± 0.07 vs 0.61 ± 0.03) experiments, but the change was not different between the two experiments ( P > 0.05). In conclusion, insulin does not stimulate muscle protein synthesis in the presence of increased circulating levels of plasma BCAA alone. Insulin's suppressive effect on proteolysis is observed independently of the levels of circulating plasma BCAA.
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Thompson, Patricia A. , Ashbeck, Erin L., Roe, Denise J. , Fales, Liane, Buckmeier, Julie A., Wang, Fang , Bhattacharyya, Achyut, Hsu, Chiu‐Hsieh , Chow, Sherry, Ahnen, Dennis J. , Heigh, Russell I., Fay, David E., Jacobs, Elizabeth T. , Alberts, David S., Lance, Peter , Buckmeier, Julie, Chow, Sherry H H, Boland, C. Richard , Hamilton, Stanley R. , Martinez, Elena Maria, Martínez, Elena

JNCI: Journal of the National Cancer Institute | August 16, 2016 | Volume: 108 | Issue: 12 | Pages: No page available

10.1093/jnci/djw151 | PMID 27530656 Get It

Does early (treatment in) BENEFIT lead to late MS benefit?
Healy, Brian C. , Weinshenker, Brian G. , Weinshenker, Brian G

Neurology | August 16, 2016 | Volume: 87 | Issue: 10 | Pages: 970-971

10.1212/wnl.0000000000003070 | PMID 27511185 Get It

FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G
Tacik, Paweł , DeTure, Michael , Carlomagno, Yari , Lin, Wen‐Lang, Murray, Melissa E. , Josephs, Keith A. , Graff‐Radford, Neill R. , Parisi, Joseph E., Petrucelli, Leonard , Rademakers, Rosa , Isaacson, Richard , Heilman, Kenneth M. , Petersen, Ronald C. , Kouri, Naomi , DeTure, Michael A, Baker, Matthew C, Baker, Matthew , Boeve, Bradley F. , Wszołek, Zbigniew K. , Dickson, Dennis W. , Murray, Melissa E

Brain Pathology | August 16, 2016 | Volume: 27 | Issue: 5 | Pages: 612-626

10.1111/bpa.12428 | PMID 27529406 Get It

AbstractMutations in microtubule‐associated protein tau gene (MAPT) cause frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP‐17). Here, we describe a patient with FTDP‐17 and a novel missense mutation in exon 13 of MAPT, p.E372G. We compare clinicopathologic features of this patient to two previously unreported patients with another exon 13 mutation, p.G389R. The patient with the p.E372G mutation was a 40‐year‐old man with behavioral variant frontotemporal dementia (bvFTD), who subsequently developed agrammatic speech and parkinsonism. One of the FTDP‐17 patients with p.G389R mutation presented at age 24 with agrammatic variant of primary progressive aphasia, and subsequently behavioral dysfunction. The other presented at age 53 with bvFTD, followed by agrammatic speech and corticobasal syndrome. Neuropathologic features of FTDP‐17 due to p.E372G were similar to those of p.G389R, including tau‐immunoreactive Pick body‐like neuronal inclusions and swollen, tapering thread‐like processes in white matter immunoreactive for 3‐repeat and 4‐repeat tau. Biochemical analysis of insoluble tau showed similar isoform compositions in p.E372G and p.G389R. Functional studies of the p.E372G mutation showed marked increase in tau filament formation and its reduced ability to promote microtubule assembly. Together these findings indicate that p.E372G is a pathogenic MAPT mutation that causes FTDP‐17 similar to p.G389R.
What is the Current Status of Optic Nerve Sheath Fenestration?
Garrity, James A.

Journal of Neuro-Ophthalmology | August 16, 2016 | Volume: 36 | Issue: 3 | Pages: 231-234

10.1097/wno.0000000000000438 | PMID 27529326 Get It

Mayo registry for telemetry efficacy in arrest (MR TEA) study: An assessment of the effect of admission diagnosis on outcomes from in-hospital cardiopulmonary arrest
Snipelisky, David , Ray, Jordan , Matcha, Gautam , Roy, Archana , Clark, Brooke, Bosworth, Veronica, Whitman, Anastasia, Lewis, Patricia , Vadeboncoeur, Tyler F. , Burton, M. Caroline , Dumitrascu, Adrian , Vadeboncoeur, Tyler, Kusumoto, Fred

Acute Cardiac Care | August 16, 2016 | Volume: 17 | Issue: 4 | Pages: 67-71

10.1080/17482941.2016.1203439 | PMID 27712143 Get It

Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging
Sugrue, Gavin , Nguyen, Ba D.

BMJ Case Reports | August 16, 2016 | Volume: 2016 | Issue: No issue available | Pages: bcr2016217038

10.1136/bcr-2016-217038 | PMID 27530882 Get It

Intra-Articular Bone Marrow Concentrate Injection Protocol: Short-Term Efficacy in Osteoarthritis
Sampson, Steven , Smith, Jay , Vincent, Hunter, Aufiero, Danielle, Zall, Mona, Botto-van-Bemden, Angie

Regenerative Medicine | August 16, 2016 | Volume: 11 | Issue: 6 | Pages: 511-520

10.2217/rme-2016-0081 | PMID 27527808 Get It